CJC-1295 No DAC adds four amino-acid substitutions to that 29-residue sequence for greater enzymatic stability
[PMID: 20166993] PubMed record related to this compound for laboratory literature review
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al
(C) Combination of RNAi and drug treatments
3-4 weeks State Appearance Retatrutide Clear, colorless CJC-1295 (No DAC) Clear, colorless Ipamorelin Clear, colorless State Oral viable Retatrutide No CJC-1295 (No DAC) No Ipamorelin No State Freeze reconstituted Retatrutide No CJC-1295 (No DAC) No Ipamorelin No Ipamorelin's 3-4 week reconstituted window is the shortest in the stack
Cancer Causes & Control , 24 (4), pp.813-816